insights_auto
Why is ARGX down 4,09%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
727,60 €
arrow_downward
-4,09%(-31,00) 1D
16 қаз., 17:39:35 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
759,20 €
High
761,80 €
Low
727,60 €
Mkt. cap
48,36 млрд
Avg. vol.
86,90 мың
Volume
96,25 мың
P/E ratio
30,95
52-wk high
925,00 €
52-wk low
568,40 €
EPS
23,51 €
Shares outstanding
35,93 млн
No. of employees
2 мың
Open
759,20 €
High
761,80 €
Low
727,60 €
Mkt. cap
48,36 млрд
Avg. vol.
86,90 мың
Volume
96,25 мың
P/E ratio
30,95
52-wk high
925,00 €
52-wk low
568,40 €
EPS
23,51 €
Shares outstanding
35,93 млн
No. of employees
2 мың
News stories
From web sources and news partners
ad-hoc-news.de
·
1 күн бұрын
argenx reports trial results: what it means for argenx stock
TipRanks
·
1 күн бұрын
Argenx Stock Stumbles As Trial Failure Haunts Rally
ad-hoc-news.de
·
2 күн бұрын
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
2 күн бұрын
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE